WO2008147169A3 - Microémulsion contenant de la pirfénidone - Google Patents

Microémulsion contenant de la pirfénidone Download PDF

Info

Publication number
WO2008147169A3
WO2008147169A3 PCT/MX2008/000068 MX2008000068W WO2008147169A3 WO 2008147169 A3 WO2008147169 A3 WO 2008147169A3 MX 2008000068 W MX2008000068 W MX 2008000068W WO 2008147169 A3 WO2008147169 A3 WO 2008147169A3
Authority
WO
WIPO (PCT)
Prior art keywords
microemulsion containing
containing pirfenidone
pirfenidone
microemulsion
capsules
Prior art date
Application number
PCT/MX2008/000068
Other languages
English (en)
Spanish (es)
Other versions
WO2008147169A8 (fr
WO2008147169A2 (fr
Inventor
Castro Jose Agustin Rogelio Magana
Borunda Juan Socorro Armendariz
Original Assignee
Magana Castro Jose Agustin Rog
Armendariz Borunda Juan Socorr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magana Castro Jose Agustin Rog, Armendariz Borunda Juan Socorr filed Critical Magana Castro Jose Agustin Rog
Publication of WO2008147169A2 publication Critical patent/WO2008147169A2/fr
Publication of WO2008147169A3 publication Critical patent/WO2008147169A3/fr
Publication of WO2008147169A8 publication Critical patent/WO2008147169A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition microémulsionnable de Pirfénidone, qui présente des avantages par rapport à d'autres formes pharmaceutiques à administrer par voie orale connues dans l'état de la technique, comme des comprimés, capsules, suspensions et solutions.
PCT/MX2008/000068 2007-05-29 2008-05-29 Microémulsion contenant de la pirfénidone WO2008147169A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2007006438 2007-05-29
MXMX/A/2007/006348 2007-05-29

Publications (3)

Publication Number Publication Date
WO2008147169A2 WO2008147169A2 (fr) 2008-12-04
WO2008147169A3 true WO2008147169A3 (fr) 2009-01-22
WO2008147169A8 WO2008147169A8 (fr) 2009-07-30

Family

ID=40075678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2008/000068 WO2008147169A2 (fr) 2007-05-29 2008-05-29 Microémulsion contenant de la pirfénidone

Country Status (1)

Country Link
WO (1) WO2008147169A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9290450B2 (en) 2008-06-03 2016-03-22 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102846555B (zh) * 2012-04-09 2014-06-25 珠海亿邦制药股份有限公司 一种以吡非尼酮为活性成分的固体制剂及其应用
CA2943363A1 (fr) 2014-04-02 2015-10-08 Intermune, Inc. Pyridinones anti-fibrotiques

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016775A1 (fr) * 1998-09-18 2000-03-30 Mepha Ag Formulation topique a base d'alkyl-, phenyl-pyridone
WO2004058256A1 (fr) * 2002-12-26 2004-07-15 Kdl, Inc. Composition pharmaceutique liquide contenant un derive de pyridone
US20060039931A1 (en) * 2002-09-13 2006-02-23 Mepha Ag Stable cream preparations of phenyl-pyridone compounds for topical application
WO2007038315A2 (fr) * 2005-09-22 2007-04-05 Intermune, Inc. Formule de capsules de pirfenidone et excipients pharmacocompatibles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016775A1 (fr) * 1998-09-18 2000-03-30 Mepha Ag Formulation topique a base d'alkyl-, phenyl-pyridone
US20060039931A1 (en) * 2002-09-13 2006-02-23 Mepha Ag Stable cream preparations of phenyl-pyridone compounds for topical application
WO2004058256A1 (fr) * 2002-12-26 2004-07-15 Kdl, Inc. Composition pharmaceutique liquide contenant un derive de pyridone
WO2007038315A2 (fr) * 2005-09-22 2007-04-05 Intermune, Inc. Formule de capsules de pirfenidone et excipients pharmacocompatibles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GARCIA SANCHEZ M.J. ET AL.: "Monografias Galenicas, Formas orales solidas (I)", LABORATORIOS GLAXO, 1993, pages 22 - 30 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9290450B2 (en) 2008-06-03 2016-03-22 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones

Also Published As

Publication number Publication date
WO2008147169A8 (fr) 2009-07-30
WO2008147169A2 (fr) 2008-12-04

Similar Documents

Publication Publication Date Title
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
WO2008037716A3 (fr) Compositions pharmaceutiques
WO2007052289A3 (fr) Nouvelle composition de comprime dispersible
WO2010066749A3 (fr) Comprimés d'ulipristal acétate
IL184126A0 (en) Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
WO2008044243A3 (fr) Nouveau procédé de préparation de statines et leurs sels pharmaceutiquement acceptables
NO20085302L (no) Farmasoytisk preparat omfattende Amlodipin og Losartan
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
JP2009537554A5 (fr)
WO2007072061A3 (fr) Formulation
WO2009081174A3 (fr) Combinaison antirétrovirale
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2008006534A3 (fr) Comprimés à multiples unités
WO2003026610A3 (fr) Procede de preparation d'une forme posologique a dissolution rapide
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2006134021A3 (fr) Procede de preparation de nouveaux sels de tiotropium, nouveaux sels de tiotropium en tant que tels et compositions pharmaceutiques associees
WO2010012459A3 (fr) Procédé de préparation de sels de solifénacine et inclusion de ces derniers dans des formes pharmaceutiques
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2008147169A3 (fr) Microémulsion contenant de la pirfénidone
WO2007007182A3 (fr) Formes galeniques solides d'agent antiepileptique
WO2008093838A1 (fr) Dérivé de pyridyl imidazolidine ayant un groupe sulfamoyle, et utilisation pharmaceutique de ce dérivé
WO2006122777A3 (fr) Utilisation de derives de thiazol-4-one 2,5-disubstitues dans des medicaments
ME01402B (fr) Procédé de synthèse de dérives de la 1,3-dihydro-2H-3-benzazepin-2-one et application à la synthèse de l'ivabradine et des sels d'addition à un acide pharmaceutiquement acceptable
HK1105872A1 (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
WO2009013594A3 (fr) Procédé de préparation de compositions solides à libération contrôlée contenant de l'oxcarbazépine, et compositions obtenues par ce procédé

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2